EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer

Benedikt Ebner, Lennert Eismann, Julian Hermans, Marc Kidess, Nikolaos Pyrgidis, Marie Semmler, Yannic Volz, Alexander Buchner, Michael Chaloupka, Marie-Lisa Eich, Philipp Weinhold, Christian G Stief und 3 weitere

Pathology - Research and Practice · 2025

DOI: 10.1016/j.prp.2025.155960 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathology - Research and Practice, 2025. Verfasst von Benedikt Ebner und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany. Electronic address: Benedikt.Ebner@med.uni-muenche…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Cyclin-Dependent Kinase Inhibitor p21, Tumor Suppressor Protein p53, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Muscle-invasive bladder cancer (MIBC) represents a genetically heterogeneous disease with limited prognostic markers. This study aimed to validate the prognostic relevance of combined alterations in cell cycle regulators RB1, p53, and p21 in a broad cohort of MIBC patients undergoing radical cystectomy (RC). MATERIAL AND METHODS: We analyzed formalin-fixed paraffin-embedded material from MIBC patients who underwent RC at the Department of Urology, University Hospital, Ludwig-Maximilians-University Munich. Tissue microarrays (TMAs) from 251 MIBC patients (pT2-pT4) were constructed, incorporating triplicate cores from tumor center and front. Immunohistochemical expression of RB1, p53, and p21 was assessed using a four-grade scoring system. Prognostic associations with overall survival (OS) and cancer-specific survival (CSS) were evaluated using multivariable Cox regression, Kaplan-Meier curves, and log-rank tests. RESULTS: We assessed 4518 stainings from 251 patients. Single marker analysis revealed no significant association between the loss of RB1, p53, or p21 and OS or CSS. However, the loss of two or three markers was significantly associated with worse OS (HR 3.49, 95 % CI 1.28-9.50; p = 0.01) and CSS (HR 11.2, 95 % CI 1.46-86.04; p = 0.02). CONCLUSIONS: RB1, p53, and p21 are insufficient as single prognostic markers in MIBC but demonstrate significant prognostic relevance when analyzed in combination. These findings underscore the need for multi-marker approaches in prognostic modeling and personalized treatment strategies for MIBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Urinary Bladder NeoplasmsCyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53Biomarkers, TumorRetinoblastoma Binding ProteinsUbiquitin-Protein LigasesHumansFemaleMaleAgedMiddle AgedPrognosisAged, 80 and overNeoplasm InvasivenessAdult

Stichwörter der Autor:innen

MIBCMuscle-invasive bladder cancerP21P53Prognostic markersRB1Urothelial carcinoma

Substanzen

Cyclin-Dependent Kinase Inhibitor p21Tumor Suppressor Protein p53Biomarkers, TumorCDKN1A protein, humanRB1 protein, humanRetinoblastoma Binding ProteinsTP53 protein, humanUbiquitin-Protein Ligases

Autor:innen und Institutionen

  • Department of Urology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany. Electronic address: Benedikt.Ebner@med.uni-muenchen.de.
  • Department of Urology, University Hospital, Ludwig-Maximilians-University Munich, Munich, Germany.
  • Institute of Pathology, University Hospital Cologne, Cologne, Germany.
  • Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin Institute of Health, Berlin, Germany.
  • Institute of Pathology, University Hospital Cologne, Cologne, Germany; Institute of Pathology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin and Berlin…

Zitieren

APA

Ebner, B., Eismann, L., Hermans, J., Kidess, M., Pyrgidis, N., Semmler, M., Volz, Y., Buchner, A., Chaloupka, M., Eich, M. L., Weinhold, P., Stief, C. G., Horst, D., Schulz, G. B., & Schallenberg, S. (2025). Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer. Pathology - Research and Practice. https://doi.org/10.1016/j.prp.2025.155960

Vancouver

Ebner B, Eismann L, Hermans J, Kidess M, Pyrgidis N, Semmler M, et al. Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer. Pathology - Research and Practice. 2025. doi:10.1016/j.prp.2025.155960

BibTeX
@article{Ebner2025,
  author = {Ebner, Benedikt and Eismann, Lennert and Hermans, Julian and Kidess, Marc and Pyrgidis, Nikolaos and Semmler, Marie and Volz, Yannic and Buchner, Alexander and Chaloupka, Michael and Eich, Marie-Lisa and Weinhold, Philipp and Stief, Christian G and Horst, David and Schulz, Gerald B and Schallenberg, Simon},
  title = {Prognostic impact of combined loss of RB1, p53 and p21 in muscle-invasive bladder cancer},
  journal = {Pathology - Research and Practice},
  year = {2025},
  doi = {10.1016/j.prp.2025.155960}
}
Kostenlos starten →